China patent law and implications for international pharmaceutical companies

被引：3

作者：

Deng, Michelle M. ^{[1
]}

机构：

[1] Genzyme Corp, 500 Kendall St, Cambridge, MA 02142 USA

来源：

EXPERT REVIEW OF CLINICAL PHARMACOLOGY | 2010年 / 3卷 / 06期

关键词：

biotechnology; China; patent law; patent law amendment; patent rights; pharmaceutical;

D O I：

10.1586/ECP.10.54

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：713 / 716

页数：4

共 50 条

[41] Update on Patent Law Revisions in China
Haile, Lisa A.
GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2009, 29 (01): : 10 - 10
[42] The Resent Development of Patent Law in China
LI Mingde Intellectual Property Center
Bulletin of the Chinese Academy of Sciences, 2011, 25 (04) : 292 - 294
[43] Comparing patent law in China and the US
Heines, MH
CHEMICAL ENGINEERING PROGRESS, 1996, 92 (01) : 18 - 18
[44] STRENGTHENING INDIA PATENT SYSTEM - IMPLICATIONS FOR PHARMACEUTICAL SECTOR
PRASAD, HAC
BHAT, S
ECONOMIC AND POLITICAL WEEKLY, 1993, 28 (21) : 1037 - 1058
[45] Nonobviousness of pharmaceutical inventions: implications for patent prosecution and litigation
Dhulap, Sivakami
Kulkarni, Mohan
PHARMACEUTICAL PATENT ANALYST, 2019, 8 (04) : 91 - 107
[46] National, corporate, and professional identities in international pharmaceutical companies
Miller, R
CANADIAN JOURNAL OF INFORMATION AND LIBRARY SCIENCE-REVUE CANADIENNE DES SCIENCES DE L INFORMATION ET DE BIBLIOTHECONOMIE, 2003, 27 (04): : 80 - 80
[47] International Strategy for Sustainable Growth in Multinational Pharmaceutical Companies
Teramae, Fumio
Makino, Tomohiro
Lim, Yeongjoo
Sengoku, Shintaro
Kodama, Kota
SUSTAINABILITY, 2020, 12 (03)
[48] International patent law—boon or bane of biotech?
Paroma Basu
Nature Biotechnology, 2005, 23 : 13 - 15
[49] China Rising: International Patent Applications
Calamia, Joseph
IEEE SPECTRUM, 2011, 48 (07) : 68 - 68
[50] International Patent Law is Obsolete and Copyright is Obsolete
Cullis, Roger
JOURNAL OF INTELLECTUAL PROPERTY LAW & PRACTICE, 2006, 1 (13) : 867 - 868

← 1 2 3 4 5 →